Article Details
Retrieved on: 2020-11-25 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<b>Pfizer</b> has dosed the first patient in its phase 3 study of marstacimab, an investigational drug being evaluated for the treatment of severe haemophilia A ...
Article found on: www.pmlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here